Renee Lentini, Principal FIN & Accounting Officer at ImmunoGen, Inc. (IMGN), sold 296,554 shares at $17.55 ($5.2M) on 2023-08-02, disclosed to the SEC on 2023-08-04.
Open-market sale of $5.2M IMGN by Principal FIN & Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.55 | 148,277 | $2.6M | 50.0% |
| 2 | $17.55 | 148,277 | $2.6M | 50.0% |
| Total | $17.55 avg | 296,554 | $5.2M | 100% |
| Filing → |
| IMGN | SELL | 2023-11-08 | $6.7M | — | Filing → |